FDA Panel Approves Pfizer Covid Booster For 65 And Ap, High Risk

8 905
8.9%
MSNBC4.52M
Published on 17 Sep 2021, 22:27
An FDA panel has voted to recommend approval of a Pfizer Covid-19 booster shot for people 65 years and older as well as those at high risk. 
» Subscribe to MSNBC: on.msnbc.com/SubscribeTomsnbc

MSNBC delivers breaking news, in-depth analysis of politics headlines, as well as commentary and informed perspectives. Find video clips and segments from The Rachel Maddow Show, Morning Joe, Meet the Press Daily, The Beat with Ari Melber, Deadline: White House with Nicolle Wallace, The ReidOut, All In, Last Word, 11th Hour, and more.

Connect with MSNBC Online
Visit msnbc.com: on.msnbc.com/Readmsnbc
Subscribe to MSNBC Newsletter: http://MSNBC.com/NewslettersYo...
Find MSNBC on Facebook: on.msnbc.com/Likemsnbc
Follow MSNBC on Twitter: on.msnbc.com/Followmsnbc
Follow MSNBC on Instagram: on.msnbc.com/Instamsnbc

#MSNBC #Covid #Coronavirus
newsautotechmusickids